After Hours
$
241.05
Change
-2.25 -0.92%
Volume
Volume 126,211
Jun 30, 2022, 6:55 p.m.
Quotes are delayed by 20 min
Previous close
$ 245.43
$ 243.30
Change
-2.13 -0.87%
Day low
Day high
$240.73
$245.00

52 week low
52 week high
$198.64
$258.45

Market cap
$131.11B
Average volume
3.44M
P/E ratio
23.97
Rev. per Employee
$1.09M
EPS
10.15
Dividend
1.94
Div yield
3.19%
Ex dividend date
5/16/22
MarketWatch News on AMGN
-
The Days of Big Pharma Are Over. What Big Biotech Means for Investors.
- Josh Nathan-Kazis
-
All 30 Dow stocks are trading lower, led by AmEX, Salesforce
- Tomi Kilgore
-
Amgen Inc., Nike share losses lead Dow's nearly 50-point fall
- MarketWatch Automation
-
Amgen Inc., Microsoft share losses lead Dow's 100-point drop
- MarketWatch Automation
-
Amazon Is Splitting Its Stock. Who's Next, and Why It Matters.
- Eric J. Savitz
-
How to Avoid the Biotech Bear Market: Get Some Products Approved
- Josh Nathan-Kazis
-
Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion
- Lina Saigol
-
Biotech Stocks Are Having a Terrible Year. These 10 Are Still Winning.
- Josh Nathan-Kazis
-
Stocks Had a Great Day. Tech Lit the Fire.
- Jack Denton
-
Dow's 38-point fall led by losses in Amgen Inc., Caterpillar stocks
- MarketWatch Automation
-
Amgen stock sinks 4.0% to pace the Dow's premarket decliners after Q1 results late Wednesday
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval
- MarketRealist.com
-
Analysts’ Latest Recommendations on Mylan
- MarketRealist.com
-
Analysts Raise Their 12-Month Target Price on Teva Pharmaceutical
- MarketRealist.com
Other News on AMGN
-
Marketplace Roundtable - Part 6 - Biotech And Healthcare
- Seeking Alpha
-
Amgen to sell Turkish unit Gensenta for $135M
- Seeking Alpha
-
SCHD: Why It Is Poised To Disappoint
- Seeking Alpha
-
Amgen's Big Bet on Copycat Drugs Is Paying Off
- GuruFocus.com
-
My Top Dividend Growth Pick In Each GICS Sector
- Seeking Alpha
-
2 Stocks That Could Survive the Next Recession
- Motley Fool
-
The 3-Bucket SWAN Portfolio For The Good Times And Bad
- Seeking Alpha
-
Could 2023 Be a Breakout Year for This Pharma Stock?
- Motley Fool
- Loading more headlines...
Press Releases on AMGN
-
- MarketNewsVideo.com
-
Multiple Myeloma Treatment Drugs Market Demand, and Forecast to 2029
- AmericaNewsHour
-
- Stock Traders Daily
-
Migraine Treatment Drugs Market Size, Share | Global Report [2028]
- AmericaNewsHour
-
- MarketNewsVideo.com
-
Amgen AMGN Investment Analysis
- Stock Traders Daily
-
AMGEN ANNOUNCES WEBCAST OF GOLDMAN SACHS 43RD ANNUAL HEALTHCARE CONFERENCE
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com